119 related articles for article (PubMed ID: 22804732)
21. Malaria, anti malarial drugs and the role of melatonin.
Srinivasan V; Mohamed M; Zakaria R; Ahmad AH
Infect Disord Drug Targets; 2012 Oct; 12(5):371-9. PubMed ID: 23082960
[TBL] [Abstract][Full Text] [Related]
22. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
23. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
Yanow SK; Purcell LA; Spithill TW
Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
[TBL] [Abstract][Full Text] [Related]
24. Melatonin activates FIS1, DYN1, and DYN2 Plasmodium falciparum related-genes for mitochondria fission: Mitoemerald-GFP as a tool to visualize mitochondria structure.
Scarpelli PH; Tessarin-Almeida G; Viçoso KL; Lima WR; Borges-Pereira L; Meissner KA; Wrenger C; Raffaello A; Rizzuto R; Pozzan T; Garcia CRS
J Pineal Res; 2019 Mar; 66(2):e12484. PubMed ID: 29480948
[TBL] [Abstract][Full Text] [Related]
25. Changes in var gene mRNA levels during erythrocytic development in two phenotypically distinct Plasmodium falciparum parasites.
Dahlbäck M; Lavstsen T; Salanti A; Hviid L; Arnot DE; Theander TG; Nielsen MA
Malar J; 2007 Jun; 6():78. PubMed ID: 17565661
[TBL] [Abstract][Full Text] [Related]
26. N1-acetyl-N2-formyl-5-methoxykynuramine modulates the cell cycle of malaria parasites.
Budu A; Peres R; Bueno VB; Catalani LH; Garcia CR
J Pineal Res; 2007 Apr; 42(3):261-6. PubMed ID: 17349024
[TBL] [Abstract][Full Text] [Related]
27. Melatonin-induced temporal up-regulation of gene expression related to ubiquitin/proteasome system (UPS) in the human malaria parasite Plasmodium falciparum.
Koyama FC; Azevedo MF; Budu A; Chakrabarti D; Garcia CR
Int J Mol Sci; 2014 Dec; 15(12):22320-30. PubMed ID: 25479077
[TBL] [Abstract][Full Text] [Related]
28. The structurally related auxin and melatonin tryptophan-derivatives and their roles in Arabidopsis thaliana and in the human malaria parasite Plasmodium falciparum.
Koyama FC; Carvalho TL; Alves E; da Silva HB; de Azevedo MF; Hemerly AS; Garcia CR
J Eukaryot Microbiol; 2013; 60(6):646-51. PubMed ID: 24102716
[TBL] [Abstract][Full Text] [Related]
29. Melatonin and IP3-induced Ca2+ release from intracellular stores in the malaria parasite Plasmodium falciparum within infected red blood cells.
Alves E; Bartlett PJ; Garcia CR; Thomas AP
J Biol Chem; 2011 Feb; 286(7):5905-12. PubMed ID: 21149448
[TBL] [Abstract][Full Text] [Related]
30. The Plasmodium falciparum-infected red blood cell.
Tilley L; Dixon MW; Kirk K
Int J Biochem Cell Biol; 2011 Jun; 43(6):839-42. PubMed ID: 21458590
[TBL] [Abstract][Full Text] [Related]
31. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
Chotivanich K; Udomsangpetch R; Dondorp A; Williams T; Angus B; Simpson JA; Pukrittayakamee S; Looareesuwan S; Newbold CI; White NJ
J Infect Dis; 2000 Aug; 182(2):629-33. PubMed ID: 10915102
[TBL] [Abstract][Full Text] [Related]
32. Isolation of erythrocytes infected with viable early stages of Plasmodium falciparum by flow cytometry.
Philipp S; Oberg HH; Janssen O; Leippe M; Gelhaus C
Cytometry A; 2012 Dec; 81(12):1048-54. PubMed ID: 23136095
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism.
Choubey V; Maity P; Guha M; Kumar S; Srivastava K; Puri SK; Bandyopadhyay U
Antimicrob Agents Chemother; 2007 Feb; 51(2):696-706. PubMed ID: 17145794
[TBL] [Abstract][Full Text] [Related]
34. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
Ellekvist P; Colding H
Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
[TBL] [Abstract][Full Text] [Related]
35. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S
Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676
[TBL] [Abstract][Full Text] [Related]
36. Threonine peptidases as drug targets against malaria.
Tschan S; Mordmüller B; Kun JF
Expert Opin Ther Targets; 2011 Apr; 15(4):365-78. PubMed ID: 21281254
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium kinases as targets for new-generation antimalarials.
Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
[TBL] [Abstract][Full Text] [Related]
38. Antimalarial drug therapy: the role of parasite biology and drug resistance.
Daily JP
J Clin Pharmacol; 2006 Dec; 46(12):1487-97. PubMed ID: 17101748
[TBL] [Abstract][Full Text] [Related]
39. PfMyb1, a Plasmodium falciparum transcription factor, is required for intra-erythrocytic growth and controls key genes for cell cycle regulation.
Gissot M; Briquet S; Refour P; Boschet C; Vaquero C
J Mol Biol; 2005 Feb; 346(1):29-42. PubMed ID: 15663925
[TBL] [Abstract][Full Text] [Related]
40. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
